- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 137.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 139M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 139.9M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $9M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $62M |
| Capex | Q1 2026 · Mar 31, 2026 | $36M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $39M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $42M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$42M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.1B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.1B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $232M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $231M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $573M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $928M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $948M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.11B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.07B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.79B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.77B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.17B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.1B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.92B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.92B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $110M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $115M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $39M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $40M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$17M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$19M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$21M |
| Revenue | Q1 2026 · Mar 31, 2026 | $606M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $612M |